meddevicedb.com FDA Device Reference

DBX DEMINERALIZED BONE MATRIX MIX

K063676 Class II Traditional
Decision Date
2007-03-05
Sponsor / Applicant
Musculoskeletal Transplant Foundation

Technical Specification

510(k) Submission ID K063676
Product Code MBP
Medical Specialty / Panel Orthopedic
Regulation Citation 21 CFR 888.3045
Decision Date 2007-03-05
Clearance Pathway Traditional

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

DBX DEMINERALIZED BONE MATRIX MIX received FDA 510(k) clearance under submission number K063676, sponsored by Musculoskeletal Transplant Foundation. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2007-03-05.

Classification & Regulation

This clearance is catalogued under FDA product code MBP and 21 CFR 888.3045, within the Orthopedic review panel as a Class II device.